A life-support machine that temporarily replaces the heart and lungs — known as extracorporeal membrane oxygenation (ECMO) — boosts survival…
Articles by Steve Bryson, PhD
Echinacoside (ECH), a naturally occurring compound derived from certain plants, particularly echinacea, was shown to ease the signs and symptoms…
Researchers have pinpointed Jagged-2, a signaling protein, as a potential therapeutic target for slowing or halting the progression of…
Overproduction of the naturally occurring hormone adrenomedullin, or ADM, helped protect neonatal mice from experimental bronchopulmonary dysplasia (BPD) and related…
Researchers have identified distinct genetic changes tied to the severity of idiopathic pulmonary arterial hypertension (IPAH) and chronic…
Treatment with anticoagulants, also known as blood thinners, does not extend survival in people with pulmonary arterial hypertension (PAH),…
Global death rates and levels of disability among newborns with pulmonary arterial hypertension (PAH) have declined since 1990, while…
Researchers used computer-based modeling to develop a measure, called pulmonary vascular compromise (PVC), which estimates the reduced function of the…
A new sequential strategy successfully treats people with severe chronic thromboembolic pulmonary hypertension (CTEPH), significantly reducing high blood pressure…
Winrevair (sotatercept-csrk), when added to standard of care, reduced clinical worsening events by 76% in adults recently diagnosed with…
Stem cell-derived conditioned medium, or the liquid that remains after cells are cultured, reduces the signs of pulmonary arterial…
Phaware, a global advocacy organization, is launching a special podcast series to raise awareness of pulmonary arterial hypertension…